REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Codepharm Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Medical Equipment and Supplies Manufacturing | Chemical and Allied Products Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Electronic Shopping and Mail-Order Houses | Rental and Leasing Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Codepharm Sp. z o.o. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Codepharm Sp. z o.o. is based in Poland. The head office is in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on July 10, 2009. The total number of employees is currently 4 (2015).

Headquarters
Ul. Zlota 61/100
Warsaw; Mazowieckie; Postal Code: 00-819

Contact Details: Purchase the Codepharm Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Codepharm Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Codepharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Codepharm Sp. z o.o. report to view the information.
Incorporation Date:
July 10, 2009
Key Executives
Company Performance
Financial values in the chart are available after Codepharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
55.53%▲
Net Profit (Loss) for the Period
55.53%▲
Total equity
-0.07%▼
Return on Equity (ROE)
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo